Showing results (1421-1430 of 4,166) with videos related to

Sort By:
Pageof 417
Translational Cancer Research|February 4, 2022
Neurological paraneoplastic syndrome caused by small cell lung cancer: a case reportWenxing Yan, Xinyu Wang, Ying Wang, et al.
Translational Cancer Research|February 4, 2022
Long-term survival of an unresectable upper thoracic esophageal squamous cell carcinoma with severe dysphagia following nasogastric tube feeding and camrelizumab-containing therapy: a case reportTingting Wang, Rong Wang, Lianke Liu
Translational Cancer Research|February 4, 2022
Pazopanib as salvage therapy in metastatic renal cell carcinoma with hypercalcemic crisis and renal insufficiency: a case report and literature reviewYing Chen, Xiaoming Ling, Wencui Kong, et al.
Translational Cancer Research|February 4, 2022
Rectal metastasis from a previously resected carcinoma of the pancreas: a case reportJing Sun, Xiao Zhang, He Huang, et al.
Translational Cancer Research|February 4, 2022
Postoperative diffused alveolar hemorrhage complicated by pneumonia after lung cancer surgery in a patient with liver cirrhosis: a case report and review of literaturesXiaheng Deng, Quan Zhu, Jun Wang, et al.
Translational Cancer Research|February 4, 2022
The natural history of oral mucosal lesions with both lichenoid and epithelial dysplastic features: a systematic reviewA Thirumal Raj, Shyam S Behura, Sachin C Sarode, et al.
Translational Cancer Research|February 4, 2022
Histomorphometric comparative analysis between the oral mucosa of fibrous inflammatory hyperplasia and oral leukoplakiaGiselle Diniz Guimarães da Silva, Tiago Novaes Pinheiro
Translational Cancer Research|February 4, 2022
Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic reviewAli Hatem Manfi Al-Rudayni, Divya Gopinath, Mari Kannan Maharajan, et al.
Translational Cancer Research|February 4, 2022
Reviewing the oral carcinogenic potential of E-cigarettes using the Bradford Hill criteria of causationA Thirumal Raj, Govindarajan Sujatha, Jayanandan Muruganandhan, et al.
Translational Cancer Research|February 4, 2022
The safety of first and subsequent lines of PD-1/PD-L1 inhibitors monotherapy in non-small cell lung cancer patients: a meta-analysisYilin Yang, Peilin Pang, Zihong Xie, et al.
Pageof 417